Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
MEDIWELCOME HEALTHCARE MANAGEMENT & TECHNOLOGY INC. Mediwelcome Healthcare Management & Technology Inc. Stock price
Equities
2159
KYG5960A1076
Business Support Services
|
Delayed
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 0.43 HKD | -5.49% | -17.31% | -68.84% | |
| Sales 2022 | 323M 45.2M 353M | Sales 2023 * | - | Capitalization | 244M 34.07M 266M |
|---|---|---|---|---|---|
| Net income 2022 | -89M -12.44M -97.21M | Net income 2023 * | - | EV / Sales 2022 | 0,36x |
| Net cash position 2022 | 128M 17.83M 139M | Net cash position 2023 * | - 0 0 | EV / Sales 2023 * | - |
| P/E ratio 2022 | -2,54x | P/E ratio 2023 * | Employees | 419 | |
| Yield 2022 | - | Yield 2023 * |
-
| Free-Float | 38.24% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -5.49% | ||
| 1 week | -17.31% | ||
| Current month | -15.69% | ||
| 1 month | -35.82% | ||
| 3 months | -36.76% | ||
| 6 months | -58.25% | ||
| Current year | -68.84% |
1 week
0.43
0.51
1 month
0.430.88
Current year
0.431.96
1 year
0.431.96
3 years
0.434.81
5 years
0.434.81
10 years
0.434.81
| Managers | Title | Age | Since |
|---|---|---|---|
Liang Wang
FOU | Founder | 48 | 2000 |
Siu Wai Tsoi
DFI | Director of Finance/CFO | - | - |
Hai Dong Jiang
CTO | Chief Tech/Sci/R&D Officer | 48 | 2019 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rui Lin Song
BRD | Director/Board Member | 60 | 2020 |
Xiang Fei
BRD | Director/Board Member | 51 | 2020 |
Liang Wang
FOU | Founder | 48 | 2000 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-07 | 0.43 | -5.49% | 28 800 |
| 23-12-07 | 0.455 | -1.09% | 90,400 |
| 23-12-06 | 0.46 | -1.08% | 81,600 |
| 23-12-05 | 0.465 | -1.06% | 143,200 |
| 23-12-04 | 0.47 | -9.62% | 2,032,000 |
Delayed Quote Hong Kong Stock Exchange, December 07, 2023 at 10:14 pm EST
More quotes
Mediwelcome Healthcare Management & Technology Inc is a China-based investment holding company that mainly provides comprehensive medical marketing solutions for cardiovascular and cerebrovascular diseases. The Company mainly provides medical conference services, patient education and self-test services, marketing strategy and consulting services, contract research agency services, and Internet hospital services. The Company mainly conducts business within the domestic market.
Sector
Business Support Services
Calendar
2024-03-27
- Q4 2023 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -68.84% | 12 M $ | |
| +23.31% | 13 181 M $ | |
| +42.83% | 824 M $ | |
| +39.20% | 723 M $ | |
| +2.29% | 695 M $ | |
| +44.92% | 317 M $ | |
| +11.63% | 230 M $ | |
| -10.69% | 200 M $ | |
| +24.39% | 101 M $ | |
| -29.79% | 89 M $ |
